Brenda M. Maloney Shafer

Publications and Presentations

07/13/22 – Presentation "2022 Pharmacy Law Symposium" Quarles & Brady Seminar Brenda Maloney Shafer, Christopher T. Dang, Roger N. Morris, Theodore M. Sullivan, Kirti Vaidya Reddy, Mark W. Bina, Edward D. Rickert, Nicholas H. Meza, John E. Hintz, Ryan L. Torres, Richard B. Davis, Michael French, Katea M. Ravega, Anne M. O'Brien, Laura Tepich MacDonald, Elizabeth R. Gebarski, Amy Cotton Peterson, Susan Brichler Trujillo

05/24/22 – Article 340B Program Compliance in a Shifting Landscape: What Challenges Do Stakeholders Face? American Health Law Association Brenda M. Shafer, Michael French, Richard B. Davis

04/06/21 – Article "To Be or Not to 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback" Pratt's Government Contracting Law Report By: Brenda M. Maloney Shafer, Richard B. Davis

Customer in pharmacy holding medicine bottle. Woman reading the label text about medical information or side effects in drug store. Patient shopping pills for migraine or flu.

01/05/21 – Blog The End of a Wild Year for 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback To Be Or Not To 340B Brenda M. Maloney Shafer, Richard B. Davis

07/18/19 "The 340B Drug Pricing Program Year in Review: What's Smoke and What's Fire in a Changing Landscape" Quarles & Brady Pharmacy Law Symposium

07/09/19 – Blog 340B Litigation Updates and Other Program Developments To Be or Not to 340B Brenda M. Shafer, Richard B. Davis

02/25/19 – Blog "CVS Caremark Reverses Planned Payment Cuts to 340B Providers" To Be or Not to 340B Brenda M. Shafer, Richard B. Davis

01/29/19 – Blog "We're 340Back! Review of Major Developments to the 340B Program" To Be or Not to 340B Brenda M. Shafer and Richard B. Davis